Xiaoliang Li

1.9k citations
83 papers · 1.3k indexed · h-index 21
Topics
Animal Virus Infections Studies (24 papers)Virus-based gene therapy research (15 papers)Viral gastroenteritis research and epidemiology (9 papers)
Partner nations
ChinaAustraliaNepal

In The Last Decade

Xiaoliang Li

77 papers receiving 1.3k citations

Peers

Xiaoliang Li
Comparison fields: 5 of 108
  • Molecular Biology 384
  • Animal Science and Zoology 341
  • Genetics 243
  • Infectious Diseases 243
  • Epidemiology 147
Replace Xiaoping Ma with:
Xiaoping Ma China
Alessio Soggiù Italy
Susanna Cirera Denmark
Michael T. Rose United Kingdom
Jan F. Richter Germany
Baohua Zhao China
Xin Yang China
Jae‐Ho Jeong South Korea
Lei Liu China
Angelica Van Goor United States
Xiaoliang Li relative to Xiaoping Ma China Xiaoping Ma's profile →
Citations per field
00.5×2.6×
Xiaoping Ma · 1×
Citations per year

Countries citing papers authored by Xiaoliang Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoliang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoliang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoliang Li more than expected).

Fields of papers citing papers by Xiaoliang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoliang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoliang Li. The network helps show where Xiaoliang Li may publish in the future.

Co-authorship network of co-authors of Xiaoliang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoliang Li. A scholar is included among the top collaborators of Xiaoliang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoliang Li. Xiaoliang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 2
6 5
7 1
8 12
9 9
10 17
11 18
12 16
13 9
14 8
15 27
16 6
17 25
18 17
19 14
20 14

About Xiaoliang Li

Xiaoliang Li is a scholar working on Animal Science and Zoology, Endocrinology and Infectious Diseases, having authored 83 papers that have together received 1.3k indexed citations. Recurring topics across this work include Animal Virus Infections Studies (24 papers), Virus-based gene therapy research (15 papers) and Viral gastroenteritis research and epidemiology (9 papers). The work is most often cited by research in Animal Science and Zoology (341 citations), Infectious Diseases (243 citations) and Molecular Medicine (63 citations). Xiaoliang Li has collaborated with scholars based in China, Australia and Nepal. Frequent co-authors include Weihuan Fang, Yingshan Zhou, Ying Shan, Yikai Zhang, Fei Xu, Min Yue, Binglin Zhu, Jiangbing Shuai, Yuan-xing Gu and Narayan Paudyal. Their work appears in journals such as PLoS ONE, Applied and Environmental Microbiology and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026